Xenia Riera

Xenia Riera

Auto-generated profile, based on publicly available information

Xenia Riera

Department of Pathology, Hospital del Mar, Hospital del Mar Research Institute-IMIM, 08003 Barcelona, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
NPNATALIA PAPALEO
NATALIA PAPALEO
AMAndrea Molina-Alvarez
Andrea Molina-Alvarez
RORicard Onieva
Ricard Onieva
DFDiana Fuertes
Diana Fuertes
BSBlanca Sanchez-Gonzalez
Blanca Sanchez-Gonzalez
Luis ColomoLuis Colomo
Luis Colomo
Background: LMO2 is a relevant gene involved in B-cell ontogeny and a survival predictor of aggressive large B-cell lymphomas (aLBCL). Most studies assessing LMO2 mRNA expression have relied on microarray platforms or qRT-PCR methods, overlooking tissue morphology. In this study, we evaluate LMO2 RNA expression by chromogenic in situ hybridization (CISH) in normal tissue and in a series of 82 aLBCL. Methods: LMO2 CISH was performed in formalin-fixed paraffin-embedded tissues, scored by three different methods, and correlated with a transcriptome panel. Results: We obtained statistically significant results correlating the methods of evaluation with LMO2 protein expression and gene expression results. Normal tonsil tissue showed high levels of LMO2, particularly within the light zone of the germinal center. Conversely, in aLBCL, a notable reduction in LMO2 expression was noted, remarkably in cases carrying MYC rearrangements. Furthermore, significant results were obtained through overall survival and Cox regression survival analysis, incorporating International Prognostic Index data alongside LMO2 expression levels. Conclusions: We show a reliable method to identify LMO2 mRNA expression by CISH, effectively capturing many of the reported biologic features of LMO2.